Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review
Authors' conclusion
This review aims to highlight and address significant gaps in cardio-oncology practice by offering clinicians an evidence-informed roadmap for managing this complex patient population.
Study context
- Population
- Patients with immune checkpoint inhibitor (ICI)-associated myocarditis after hospital discharge
Original publication
Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review. JACC CardioOncol. Published October 2026. doi:10.
Summarised from the published abstract; every number is checked against it